FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Hydrochlorothiazide and Lisinopril Tablets
Status: Discontinuation
»Therapeutic Categories: Cardiovascular

Expand all

Mylan Pharmaceuticals Inc. (New 05/22/2018)

Company Contact Information:
800-796-9526

Presentation Posting Date Related Information
20 mg/25 mg (NDC 0378-2025-01) 05/22/2018 The discontinuation of this product is a business decision
12.5 mg/ 20 mg (NDC 0378-2012-01) 05/22/2018 The discontinuation of this product is a business decision
10 mg/ 12.5 mg (NDC 0378-1012-01) 05/22/2018 The discontinuation of this product is a business decision

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English